# OnCo record nct04274738 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04274738/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04274738", "NCT04274738" ;
  schema:name "A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4"@en ;
  schema:description "A phase 1 trial of Mavorixafor and Ibrutinib in Waldenström macroglobulinaemia, run by X4 Pharmaceuticals, completed."@en ;
  schema:url <https://onco.cc/trials/nct04274738/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04274738> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/waldenstrom/> ;
  onco:drugs <https://onco.cc/drugs/mavorixafor/>, <https://onco.cc/drugs/ibrutinib/> ;
  onco:companies <https://onco.cc/companies/x4-pharmaceuticals/> .